Model for SorCS1-mediated Diabetes with Dementia
SorCS1 介导的糖尿病伴痴呆模型
基本信息
- 批准号:8788636
- 负责人:
- 金额:$ 37.08万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-01-15 至 2016-12-31
- 项目状态:已结题
- 来源:
- 关键词:AgingAlzheimer&aposs DiseaseAlzheimer&aposs disease riskAmyloid beta-ProteinAmyloid beta-Protein PrecursorBrainCharacteristicsComplexCultured CellsDataDementiaDiabetes MellitusDiseaseFamilyFemaleFunctional disorderGenderGene TransferGenerationsGeneticGenetic PolymorphismHumanInsulinInsulin ResistanceLinkMediatingMetabolicMetabolismModelingMolecularMusMutationNon-Insulin-Dependent Diabetes MellitusPatientsPhenotypePhosphorylationProtein PrecursorsProteinsRiskRoleSerineStructureTertiary Protein StructureTestingTransgenic MiceVacuolar Protein SortingVertebral columnViral GenesWorkamyloid peptidegenetic associationgenetic linkageglucose metabolismglucose tolerancehippocampal morphometryhypercholesterolemiainsulin tolerancelearned behavioroverexpressionprotein complexprotein metabolismprotein transportsexual dimorphismsortilintrafficking
项目摘要
SUMMARY
Type 2 diabetes mellitus (T2D or T2DM) increases the risk for Alzheimer's disease (AD), and SORCS1 is
genetically linked to both T2D and AD. We have undertaken a study of the possible role(s) for SorCS1 in
metabolism of the Alzheimer's amyloid-¿ (¿¿) precursor protein (APP), in order to define the molecular
mechanisms underlying this coordinate genetic linkage to both diseases. Overexpression of SorCS1c¿-myc
in cultured cells caused a reduction (p=0.002) in ¿¿ generation (Lane et al., 2010). Endogenous murine
A¿40 and ¿¿42 levels were increased (A¿40, p=0.044; A¿42, p=0.007) in the brains of female Sorcs1
hypomorphic mice, possibly paralleling the sexual dimorphism that is characteristic of the genetic
associations of SORCS1 with AD and DM. Since SorL1, another AD-linked Vps10-domain protein, directly
interacts with Vps35 to modulate APP metabolism, we investigated the possibility that SorCS1c¿-myc might
interact with APP, SorL1, and/or Vps35. We readily recovered SorCS1:APP, SorCS1:SorL1, and
SorCS1:Vps35 complexes from nontransgenic mouse brain. Notably, total Vps35 protein levels were
decreased by 49% (p=0.009) and total SorL1 protein levels were decreased by 29% (p=0.003) in the brains
of female Sorcs1-/- mice. We hypothesize that dysfunction of SorCS1 may contribute to both the APP/¿¿
disturbance underlying AD and the insulin/glucose metabolism disturbance underlying DM. In order to test
this hypothesis further, we propose the following specific aims: Specific Aim 1. To evaluate the importance
of SorCS1 protein interaction motifs and SorCS1/SorL1/APP complex formation on APP metabolism by: (a)
Characterizing APP metabolism in cultured cells overexpressing SorCS1; (b) Testing the effects of
mutations of protein-protein interacting motifs in the cytoplasmic and ectodomains of SorCS1 on both the
formation of tripartite SorCS1/SorL1/APP complexes and APP metabolism; (c) Testing the effect of a
putative pathogenic SorCS1 polymorphism on both the formation of tripartite SorCS1/SorL1/APP complexes
and APP metabolism; (d) Confirming the importance of functional domains identified in Aim 1aii and 1aiii by
viral gene transfer into primary cultures. Specific Aim 2. To employ Sorcs1 hypomorphic and plaque-
forming human Swedish APP/PS bigenic mice crossed with Sorcs1 hypomorphic mice for characterization
of: (i) endogenous APP metabolism; (ii) hippocampal morphometry, dendritic arborization, and spine
structure; (c) learning behavior. Aging (3 mo, 6 mo, 12 mo) effects will also be studied. Specific Aim 3. To
perform standard glucose and insulin tolerance tests and metabolic profile phenotyping of Sorcs1-/- mice
and plaque-forming" human Swedish APP/PS co-transgenic mice crossed with Sorcs1 -/- mice.
概括
2 型糖尿病(T2D 或 T2DM)会增加患阿尔茨海默病 (AD) 的风险,而 SORCS1 是
与 T2D 和 AD 均存在遗传相关。我们对 SorCS1 的可能作用进行了研究
阿尔茨海默病淀粉样蛋白-¿ (¿¿) 前体蛋白 (APP) 的代谢,以确定分子
这种协调与两种疾病的遗传联系的机制。 SorCS1c¿-myc 的过度表达
培养细胞中的 β-内酰胺酶导致细胞世代减少 (p=0.002) (Lane et al., 2010)。内源性小鼠
女性 Sorcs1 大脑中的 A¿40 和 ¿42 水平升高(A¿40,p=0.044;A¿42,p=0.007)
亚型小鼠,可能与遗传特征的性别二态性平行
SORCS1 与 AD 和 DM 的关联。由于SorL1(另一种AD连接的Vps10结构域蛋白)直接
与 Vps35 相互作用来调节 APP 代谢,我们研究了 SorCS1c¿-myc 可能的可能性
与 APP、SorL1 和/或 Vps35 交互。我们很容易恢复了 SorCS1:APP、SorCS1:SorL1 和
来自非转基因小鼠大脑的 SorCS1:Vps35 复合物。值得注意的是,总 Vps35 蛋白水平
大脑中的 SorL1 总蛋白水平降低了 49% (p=0.009),总 SorL1 蛋白水平降低了 29% (p=0.003)
雌性 Sorcs1-/- 小鼠。我们假设 SorCS1 的功能障碍可能会导致 APP/¿
AD 潜在的紊乱和 DM 潜在的胰岛素/葡萄糖代谢紊乱。为了测试
进一步这个假设,我们提出以下具体目标: 具体目标 1. 评估重要性
SorCS1 蛋白相互作用基序和 SorCS1/SorL1/APP 复合物形成对 APP 代谢的影响:(a)
表征过度表达 SorCS1 的培养细胞中的 APP 代谢; (b) 测试效果
SorCS1 的胞质和胞外域中蛋白质-蛋白质相互作用基序的突变
SorCS1/SorL1/APP 三联复合物的形成和 APP 代谢; (c) 测试效果
推定致病性 SorCS1 多态性对三联 SorCS1/SorL1/APP 复合物形成的影响
和APP代谢; (d) 通过以下方式确认目标 1aii 和 1aiii 中确定的功能域的重要性:
病毒基因转移到原代培养物中。具体目标 2. 使用 Sorcs1 亚效型和斑块-
形成人类瑞典 APP/PS 双基因小鼠与 Sorcs1 低等态小鼠杂交以进行表征
(i) 内源性 APP 代谢; (ii) 海马形态测量、树突分枝和脊柱
结构; (c) 学习行为。还将研究老化(3 个月、6 个月、12 个月)的影响。具体目标 3. 至
对 Sorcs1-/- 小鼠进行标准葡萄糖和胰岛素耐量测试以及代谢谱表型分析
和斑块形成的”人类瑞典 APP/PS 共转基因小鼠与 Sorcs1 -/- 小鼠杂交。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SAMUEL E. GANDY其他文献
SAMUEL E. GANDY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SAMUEL E. GANDY', 18)}}的其他基金
Proneurogenic Treatment for Amyloid or Tau-Based Neurodegeneration
针对淀粉样蛋白或 Tau 神经变性的促神经源性治疗
- 批准号:
10378457 - 财政年份:2017
- 资助金额:
$ 37.08万 - 项目类别:
Proneurogenic Treatment for Amyloid or Tau-Based Neurodegeneration
针对淀粉样蛋白或 Tau 神经变性的促神经源性治疗
- 批准号:
9911993 - 财政年份:2017
- 资助金额:
$ 37.08万 - 项目类别:
Rehab Therapy Adjunct with a Neurogenic, Mnemoactive, A-Beta-Lowering Compound
含有神经源性、记忆活性、A-β 降低化合物的康复治疗辅助剂
- 批准号:
9220567 - 财政年份:2014
- 资助金额:
$ 37.08万 - 项目类别:
Rehab Therapy Adjunct with a Neurogenic, Mnemoactive, A-Beta-Lowering Compound
含有神经源性、记忆活性、A-β 降低化合物的康复治疗辅助剂
- 批准号:
8596270 - 财政年份:2014
- 资助金额:
$ 37.08万 - 项目类别:
Rehab Therapy Adjunct with a Neurogenic, Mnemoactive, A-Beta-Lowering Compound
含有神经源性、记忆活性、A-β 降低化合物的康复治疗辅助剂
- 批准号:
9026594 - 财政年份:2014
- 资助金额:
$ 37.08万 - 项目类别:
Rehab Therapy Adjunct with a Neurogenic, Mnemoactive, A-Beta-Lowering Compound
含有神经源性、记忆活性、A-β 降低化合物的康复治疗辅助剂
- 批准号:
8825927 - 财政年份:2014
- 资助金额:
$ 37.08万 - 项目类别:
Generation and Characterization of Alzheimer Brain Cells
阿尔茨海默病脑细胞的生成和表征
- 批准号:
8370239 - 财政年份:2012
- 资助金额:
$ 37.08万 - 项目类别:
Model for SorCS1-mediated Diabetes with Dementia
SorCS1 介导的糖尿病伴痴呆模型
- 批准号:
8599496 - 财政年份:2012
- 资助金额:
$ 37.08万 - 项目类别:
Model for SorCS1-mediated Diabetes with Dementia
SorCS1 介导的糖尿病伴痴呆模型
- 批准号:
8295466 - 财政年份:2012
- 资助金额:
$ 37.08万 - 项目类别:
Model for SorCS1-mediated Diabetes with Dementia
SorCS1 介导的糖尿病伴痴呆模型
- 批准号:
8411973 - 财政年份:2012
- 资助金额:
$ 37.08万 - 项目类别:














{{item.name}}会员




